00310-7820 Caprelsa - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00310-7820

Brand Name:

Caprelsa

Generic Name:

Vandetanib

Dosage Form Name:

Tablet

Administration Route:

Oral

Substances:

Name: Vandetanib

Strength: 100.0

Unit: mg/1

Packages:

Code: 00310-7820-30

Description: 30 TABLET in 1 BOTTLE, PLASTIC (0310-7820-30)

Effective Date: July 25, 2011

Discontinued: May 31, 2020

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

VEGFR, EGFR

Orphan Drug Designation:

Status:

No Longer Used